rs890647462
Variant summary
Our verdict is Uncertain significance. The variant received 1 ACMG points: 2P and 1B. PM2BP4
The NM_020708.5(SLC12A5):c.2143T>C(p.Phe715Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000025 in 1,602,490 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_020708.5 missense
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 34Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Illumina, Ambry Genetics
- epilepsy of infancy with migrating focal seizuresInheritance: AR Classification: STRONG Submitted by: G2P
- malignant migrating partial seizures of infancyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- epilepsy, idiopathic generalized, susceptibility to, 14Inheritance: AD Classification: LIMITED, NO_KNOWN Submitted by: Illumina, Ambry Genetics
- genetic developmental and epileptic encephalopathyInheritance: AR Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 1 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152202Hom.:  0  Cov.: 33 show subpopulations 
GnomAD4 exome  AF:  0.00000138  AC: 2AN: 1450288Hom.:  0  Cov.: 34 AF XY:  0.00  AC XY: 0AN XY: 719734 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000131  AC: 2AN: 152202Hom.:  0  Cov.: 33 AF XY:  0.0000134  AC XY: 1AN XY: 74352 show subpopulations 
ClinVar
Submissions by phenotype
not specified    Uncertain:1 
The c.2212T>C (p.F738L) alteration is located in exon 17 (coding exon 17) of the SLC12A5 gene. This alteration results from a T to C substitution at nucleotide position 2212, causing the phenylalanine (F) at amino acid position 738 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Epilepsy, idiopathic generalized, susceptibility to, 14;C4225257:Developmental and epileptic encephalopathy, 34    Uncertain:1 
- -
Developmental and epileptic encephalopathy, 34    Uncertain:1 
This sequence change replaces phenylalanine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 715 of the SLC12A5 protein (p.Phe715Leu). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SLC12A5-related conditions. ClinVar contains an entry for this variant (Variation ID: 574875). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt SLC12A5 protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at